Bellicum raises $60M in follow-on

Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM) raised $60 million through the sale of 5 million shares at $12 in a follow-on underwritten by Citigroup, Jefferies, Guggenheim, Ladenburg Thalmann, Raymond James and SunTrust. The price was a 16% discount to its close of $14.37 on Wednesday, when it proposed the offering after market hours. Bellicum slipped $0.86 to $12.04 on Friday...